Focus topics

Two mRNA vaccines in development

China’s ambition to one day be on a par with the EU and the US in terms of technology also affects biomedicine. Rather unnoticed by the public, two groups are working on vaccinations based on mRNA technology, which is considered the front line of modern disease control. The vaccine produced by Biontech, the majority of which is used in Germany, also uses mRNA. In the long term, China wants to enter the development and production of corresponding drugs on a large scale and become independent of the West in this area as well.

Continue reading now

Get 30 days of free access to the Decision Brief to read these and more quality news every day.

Are you already a guest at the China.Table? Log in now


    Yuan at all-time low
    Porsche hopes for cult following
    AI to mitigate risk of blackouts
    Box-office hit ‘Return to Dust’: Too authentic for Beijing